GALLIVAC IB88 NEO, šnypščiosios tabletės purškiamajai suspensijai ruošti vištoms
GALLIVAC IB88 NEO, šnypščiosios tabletės purškiamajai suspensijai ruošti vištoms
Authorised
- Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Product identification
Medicine name:
GALLIVAC IB88 NEO, šnypščiosios tabletės purškiamajai suspensijai ruošti vištoms
Active substance:
- Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Target species:
-
Chicken
Route of administration:
-
Nebulisation use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type 793/B, strain CR88121, Live4.00/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
Nebulisation use
-
Chicken
-
All relevant tissues0dayDo not vaccinate chickens during egg laying.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/15/2307/001-004
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 15/01/2026